Cancyt 100 mg Injection

Injection de Cancyt 100 mg is a targeted therapy used in the treatment of certain types of cancer. The active ingredient, Imatinib, is a tyrosine kinase inhibitor. It works by blocking specific proteins that signal cancer cells to grow and divide. By inhibiting these signals, Imatinib helps to slow down or stop the progression of cancer. It is commonly prescribed for Philadelphia chromosome-positive chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL), and certain types of gastrointestinal stromal tumors (GIST). The typical dosage and administration will be determined by a healthcare professional based on the specific condition and patient response. Common side effects may include nausea, vomiting, diarrhea, muscle cramps, fatigue, and skin rash. Serious side effects can occur, and patients should report any unusual symptoms to their doctor immediately. Storage instructions should be followed as per the manufacturer’s guidelines, typically at room temperature, protected from light and moisture.